Goals may include: improving the speed of recovery from attacks (treatment with steroid drugs); reducing the number of attacks or the number of MRI lesions; or attempting to slow progression of the disease (treatment with disease modifying drugs or DMDs).Initially, corticosteroids, such as prednisone (Deltasone, Liquid Pred, Deltasone, Orasone, Prednicen-M) or methylprednisolone (Medrol, Depo-Medrol), were widely used.However, since their effect on the immune system is non-specific (general) and they may use may cause numerous side effects, corticosteroids now tend to be used to manage only severe multiple sclerosis attacks (that is, attacks leading to physical disability or causing pain).Drugs known to affect the immune system have become the primary focus for managing multiple sclerosis.An understanding of the potential side effects of drugs is critical for the patient because sometimes side effects alone deter patients from drug therapy.There are many issues for the patient and physician to consider in treating multiple sclerosis.Finally, utilizing support groups or counseling may be helpful for patients and their families whose lives may be affected directly by multiple sclerosis.Many will begin treatment at the time of the first multiple sclerosis attack, since clinical trials have suggested that patients in whom treatment is delayed may not benefit as much as patients who are treated early.An additional goal is relief from complications due to the loss of function of affected organs (treatment with drugs aimed at specific symptoms).Most neurologists will consider treatment with DMDs once the diagnosis of relapsing remitting multiple sclerosis is established.Patients may choose to avoid drugs altogether or choose an alternative drug that may offer relief with fewer side effects.
It is important for patients to talk to their doctor before deciding to go on therapy since DMDs differ in their uses (for example, one DMD may be used for slowing progressing disability but not for treatment of the first attack of MS; another DMD may be used for reducing relapses but not for slowing progressing disability).A continuous dialogue between the patient and physician about the medications is important in determining the needs for treatment.Once goals have been set, initial therapy may include medications to manage attacks, symptoms, or both.